Clinical Development Pathway
The clinical development pathway is for students interested in the interplay between biotechnology and clinical research and development, specifically pertaining to safety and effectiveness of medications, devices, diagnostic products, and treatment regimens intended for human subjects. Coursework for this track focuses on fundamentals and concepts in:
- New product development
- Legal and regulatory affairs
- Project management
- Principles of clinical research
- Principles of toxicology
- Statistical principles of epidemiology
Recommended Elective Courses
Biochemistry (BCH) courses
- BCH 553 – Biochemistry of Gene Expression (3 credits; offered fall and spring)
- BCH 555 – Proteins and Molecular Mechanisms (3 credits; offered fall and spring)
- BCH 571 – Regulation of Metabolism (3 credits; offered fall only – alternate odd years)
Comparative Biological Sciences (CBS) courses
- CBS 565 – Fundamentals of Biomedical Sciences (3 credits; offered in fall only; instructor permission required for enrollment)
Genetics (GN) courses
- GN 521 – Molecular Genetics (3 credits; offered fall and spring)
- GN 701 – Molecular Genetics (3 credits; offered fall only)
- GN 735 – Functional Genomics (3 credits; offered spring only; prerequisite: GN 701)
Master of Business Administration (MBA) courses
- BUS 554 – Project Management (3 credit hours; offered fall and spring)
- MBA 576 – Technology Entrepreneurship and Commercialization I (3 credits; offered fall and spring)
- MBA 577 – Technology Entrepreneurship and Commercialization II (3 credits; offered fall and spring; MBA 576 is a pre-requisite)
- MBA 586 – Legal, Regulatory and Ethical Issues in Life Science Industries (3 credits; offered in fall only)
- MBA 590 – Special Topics in Business Management (3 credits)
Statistics (ST) courses
- ST 513 – Statistics for Management and Social Sciences I (3 credits; offered fall and spring)